Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:47 pm Purchase | 2024-09-30 | 13G | Tyra Biosciences, Inc. TYRA | NEXTECH VI ONCOLOGY SCSP | 4,055,861 7.700% | 1,537,279 (+61.04%) | Filing History |
| 2023-02-14 4:35 pm Unchanged | 2022-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY | NEXTECH VI ONCOLOGY SCSP | 1,910,029 2.000% | 0 (Unchanged) | Filing History |
| 2021-09-27 4:36 pm Purchase | 2021-09-17 | 13G | Tyra Biosciences, Inc. TYRA | NEXTECH VI ONCOLOGY SCSP | 2,518,582 5.900% | 2,518,582 (New Position) | Filing History |
| 2021-02-16 4:01 pm Purchase | 2020-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY | NEXTECH VI ONCOLOGY SCSP | 1,910,029 5.500% | 1,910,029 (New Position) | Filing History |